Alopecia risk factors

Revision as of 01:33, 29 January 2021 by Nnabude (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Alopecia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Alopecia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Laser Therapy

Concealing Hair Loss

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alopecia risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Alopecia risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alopecia risk factors

CDC on Alopecia risk factors

Alopecia risk factors in the news

Blogs on Alopecia risk factors

Directions to Hospitals Treating Alopecia

Risk calculators and risk factors for Alopecia risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogechukwu Hannah Nnabude, MD

Overview

Age, medications, sex, family history, and illness are all risk factors for alopecia. Androgenetic alopecia is more common in males and prevalence increases with age. People with a family history of hair loss are at a greater predisposition to developing alopecia compared to individuals who do not have a family history. Psychosocial stress, hormonal imbalance, and illness also increase the risk of alopecia.

Risk Factors

References

  1. Watras MM, Patel JP, Arya R (2016). "Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature". Drugs Real World Outcomes. 3 (1): 1–6. doi:10.1007/s40801-015-0056-z. PMC 4819463. PMID 27747798.
  2. Thomson SR, Mamulpet V, Adiga S (2017). "Sodium Valproate Induced Alopecia: A Case Series". J Clin Dia]]gn Res. 11 (9): FR01–FR02. doi:10.7860/JCDR/2017/28564.10658. PMC 5713753. PMID 29207731.
  3. HOLOWACH J, SANDEN HV (1960). "Alopecia as a side effect of treatment of epilepsy with trimethadione. Report of two cases". N Engl J Med. 263: 1187. doi:10.1056/NEJM196012082632308. PMID 13715510.
  4. Etminan M, Sodhi M, Procyshyn RM, Guo M, Carleton BC (2018). "Risk of hair loss with different antidepressants: a comparative retrospective cohort study". Int Clin Psychopharmacol. 33 (1): 44–48. doi:10.1097/YIC.0000000000000191. PMID 28763345.
  5. Shelley ED, Shelley WB (1985). "Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol". Cutis. 35 (2): 148–9. PMID 3979099.
  6. Forouzan P, Cohen PR (2020). "Systemic Lupus Erythematosus Presenting as Alopecia Areata". Cureus. 12 (6): e8724. doi:10.7759/cureus.8724. PMC 7372242 Check |pmc= value (help). PMID 32699719 Check |pmid= value (help).
  7. Callen JP (2000). "Dermatomyositis". Lancet. 355 (9197): 53–7. doi:10.1016/S0140-6736(99)05157-0. PMID 10615903.
  8. Vincent M, Yogiraj K (2013). "A Descriptive Study of Alopecia Patterns and their Relation to Thyroid Dysfunction". Int J Trichology. 5 (1): 57–60. doi:10.4103/0974-7753.114701. PMC 3746235. PMID 23960405.
  9. Guo EL, Katta R (2017). "Diet and hair loss: effects of nutrient deficiency and supplement use". Dermatol Pract Concept. 7 (1): 1–10. doi:10.5826/dpc.0701a01. PMC 5315033. PMID 28243487.
  10. Ayanlowo O, Akinkugbe A, Oladele R, Balogun M (2014). "Prevalence of Tinea Capitis Infection Among Primary School Children in a Rural Setting in South-West Nigeria". J Public Health Afr. 5 (1): 349. doi:10.4081/jphia.2014.349. PMC 5345463. PMID 28299118.
  11. Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R (2020). "Telogen Effluvium: A Review of the Literature". Cureus. 12 (5): e8320. doi:10.7759/cureus.8320. PMC 7320655 Check |pmc= value (help). PMID 32607303 Check |pmid= value (help).
  12. Billero V, Miteva M (2018). "Traction alopecia: the root of the problem". Clin Cosmet Investig Dermatol. 11: 149–159. doi:10.2147/CCID.S137296. PMC 5896661. PMID 29670386.
  13. Nicholson AG, Harland CC, Bull RH, Mortimer PS, Cook MG (1993). "Chemically induced cosmetic alopecia". Br J Dermatol. 128 (5): 537–41. doi:10.1111/j.1365-2133.1993.tb00231.x. PMID 8504045.
  14. Kische H, Arnold A, Gross S, Wallaschofski H, Völzke H, Nauck M; et al. (2017). "Sex Hormones and Hair Loss in Men From the General Population of Northeastern Germany". JAMA Dermatol. 153 (9): 935–937. doi:10.1001/jamadermatol.2017.0297. PMC 5817427. PMID 28403384.
  15. Mahmoudi H, Salehi M, Moghadas S, Ghandi N, Teimourpour A, Daneshpazhooh M (2018) Dermoscopic Findings in 126 Patients with Alopecia Areata: A Cross-Sectional Study. Int J Trichology 10 (3):118-123. DOI:10.4103/ijt.ijt_102_17 PMID: 30034191
  16. Wang S, Ratnaparkhi R, Piliang M, Bergfeld WF (2018). "Role of family history in patchy alopecia areata". Dermatol Online J. 24 (10). PMID 30677822.

Template:WikiDoc Sources